IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tang Capital Management LLC

Q3 2013 Holdings

Filed 2013-11-14 | 17 holdings | $13.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$13.2M182,30098.6%
PDL Biopharma IncNOTE 2.875% 2/15/1569329YAE4$37.6K$25,974,0000.3%
Opko Health IncNOTE 3.0% 2/1/3368375NAA1$30.9K$25,000,0000.2%
Salix Pharmaceuticals IncCOM795435106$20.1K300,0000.2%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$17.9K1,181,4000.1%
Mannkind CorpNOTE 3.750% 12/15/1356400PAA0$17.1K$17,144,0000.1%
Dendreon CorpNOTE 2.875% 1/15/1624823QAC1$16.2K$26,515,0000.1%
Intermune IncNOTE 2.50% 9/15/1845884XAE3$15.3K$17,000,0000.1%
Oncogenex Pharmaceuticals IncCOM68230A106$8.7K933,1000.1%
Savient Pharmaceuticals IncNOTE 4.750% 2/1/1880517QAA8$7.3K$30,476,0000.1%
Depomed IncCOM249908104$6.2K835,9310.0%
Endocyte IncCOM29269A102$6.2K465,7630.0%
Corsicanto LTDNOTE 3.50% 1/15/32220480AC1$2.8K$2,500,0000.0%
Sophiris BIO IncCOM83578Q209$2.3K500,0000.0%
Dendreon CorpCOM24823Q107$23379,6000.0%
Ambit Biosciences CorpCOM02318X100$0460.0%